Dr Reddy's Laboratories

Sputnik V soft launch not put on hold, clarifies Dr Reddy's Laboratories

Dr Reddy's Laboratories announces commercial launch of anti-COVID 2-DG drug

Beware! 2DG COVID medicine will not see the daylight before June

Good news! Phase 2 trial of this COVID-19 vaccine may resume in India soon

Dr Reddy's shares slip nearly 3%; mcap drops by Rs 1,082 crore

Dr Reddy's gets favourable verdict in patent litigation in US

Class action lawsuit filed against Dr Reddy's in US

DRL says no claims against it for monetary damages in US patent case

7 FDI proposals worth Rs 100 crore get FIPB approval

USFDA actions hurting exports, need govt intervention: Dr Reddy's

Dr Reddy's to invest in startups

Dr Reddy's board approves share buyback for Rs 1,569.4 crore

Dr Reddy's Q3 net profit rises marginally to Rs 579 crore

Tata Motors only Indian firm on top-50 global R&D list

USFDA gives Dr Reddy's addl time to respond to warning letter

Dr Reddy's shares slump 8.5%; m-cap dips Rs 4,746 crore

US FDA warns of DRL drug import ban if flaws are not fixed

Dr Reddy's accused of making false claims about financials, shares slump 7%

US court asks Dr Reddy's Laboratories to halt generic sale of esomeprazole